Profile
Dr. Lee Schacter is Medical Director-Oncology at Clinipace, Inc.
Dr. Schacter was previously employed as Medical Director-Marketed Oncology Products by AstraZeneca LP, a Principal by Bristol Myers Co., Executive Medical Director & Global Head-Oncology by MDS Pharma Services (US), Inc., Senior Director-Global Medical Affairs by Pfizer Inc., Chief Medical Officer by The Multiple Myeloma Research Foundation, Inc., and a Principal by Yale School of Medicine.
He received his undergraduate degree from Haverford College, a doctorate degree from the University of Miami (Florida) and a doctorate degree from Brandeis University.
Former positions of Lee Schacter
Companies | Position | End |
---|---|---|
PFIZER, INC. | Chief Tech/Sci/R&D Officer | 30/04/2011 |
Bristol Myers Co. | Corporate Officer/Principal | - |
Yale School of Medicine | Corporate Officer/Principal | - |
MDS Pharma Services (US), Inc. | Chief Tech/Sci/R&D Officer | - |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Corporate Officer/Principal | - |
Training of Lee Schacter
Brandeis University | Doctorate Degree |
Haverford College | Undergraduate Degree |
University of Miami | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
PFIZER, INC. | Health Technology |
Private companies | 5 |
---|---|
Clinipace, Inc.
Clinipace, Inc. Miscellaneous Commercial ServicesCommercial Services Clinipace, Inc. provides digital contract research solutions. The firm operates as a digital contract research organization that assists life science firms in developing and executing regulatory strategies, clinical development, and post-approval research. Its service areas encompass clinical monitoring, data management, medical affairs and writing, patient recruitment, study feasibility, and site selection and management. The company was founded by Ronald G. Marks, Christopher K. Porter, and Jeff Lewis Williams in 2003 and is headquartered in Morrisville, NC. | Commercial Services |
Bristol Myers Co. | Health Technology |
The Multiple Myeloma Research Foundation, Inc.
The Multiple Myeloma Research Foundation, Inc. Miscellaneous Commercial ServicesCommercial Services The Multiple Myeloma Research Foundation, Inc. provides funding for research on myeloma treatment. It provides funding to laboratories worldwide, including compounds and approaches in clinical trials and pre-clinical studies. The firm also facilitates clinical trials through their affiliate organization, the Multiple Myeloma Research Consortium. The company was founded by Karen E. Andrews and Kathryn E. Giusti in 1998 and is headquartered in Norwalk, CT. | Commercial Services |
AstraZeneca LP
AstraZeneca LP Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, AstraZeneca LP is a pharmaceutical company that focuses on developing and commercializing prescription drugs for various therapeutic areas. The company is based in Wilmington, DE. | Health Technology |
MDS Pharma Services (US), Inc. |
- Stock Market
- Insiders
- Lee Schacter